Hearing the special leave petition filed by  Glenmark against a judgment pronounced by the Delhi High Court, the Bench consisting of Justices Ranjan Gogoi and N.V. Ramana today injuncted Glenmark from finishing the unformulated Sitagliptin Phosphate Monohydrate, a drug for type 2 diabetes.The Court in its order said, “Going by the prima facie satisfaction recorded by the High Court, we are...